Business

Sales of Cedroz commence in Italy

Sales of Cedroz commence in Italy.

articleEden Research PlcMay 9, 20193/company/eden-research-plc/news/sales-of-cedroz-commence-in-italy
Sales of Cedroz commence in Italy

About this update from Eden Research Plc

[{"type":"text","content":"\n \nRNS Number : 4415Y Eden Research plc 09 May 2019  \n\n \n \n \n9 May 2019\n \nEden Research plc\n \n(\"Eden\" or \"Company\")\n \nSales of Cedroz™ commence in Italy\nEden Research plc (AIM: EDEN), the AIM listed company that develops and supplies breakthrough biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries, is pleased to announce that its commercial partner, Eastman Chemical Company (\"Eastman\"), has made its first sales of Cedroz™ following the recent receipt of \"emergency\" authorisation by the Italian authorities. \nCedroz, which was initially developed and patented by Eden, is an innovative and natural solution designed to combat plant parasitic nematodes, pests that are known to cause severe damage to crops globally in both open field and greenhouse horticulture, resulting in yield losses and increasing growers costs.  Eden produced and supplied Cedroz to Eastman in March this year in anticipation of regulatory clearance in Italy during the course of the 2019 growing season. \nSean Smith, Chief Executive Officer of Eden, said: \"We are pleased to see initial sales of Cedroz this early in the year following the derogation in Italy just a few weeks ago.  Eastman has seized upon this earlier-than-anticipated opportunity to launch Cedroz in order to fully develop the market for this important product, and Eden has been more than happy to support them in their efforts to move the product to commercial use as quickly as possible. \nWe look forward to continuing our work with Eastman and working with growers to combat plant parasitic nematodes with an effective and sustainable solution.\"\n \nFor further information contact:\n\n\n\n\nEden Research plc\n\n\nwww.edenresearch.com \n\n\n\n\nSean Smith\nAlex Abrey\n\n\n01285 359 555\n\n\n\n\n \n\n\n \n\n\n\n\nShore Capital (Nomad) \n\n\n020 7408 4090\n\n\n\n\nStephane Auton / Patrick Castle\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nPowerscourt (Financial PR)\n\n\n020 7250 1446\n\n\n\n\nNick Dibden\nJana Tsiligiannis \n\n\[email protected] \n\n\n\n\n \n \nNotes:\n \nEden Research is a technology development and commercialisation company with intellectual property and expertis...

More updates from Eden Research Plc